Has Ranbaxy Damaged India’s Pharma Brand?
This article was originally published in PharmAsia News
Executive Summary
Indian generics manufacturers are worried that Ranbaxy’s recent guilty plea to criminal charges in the U.S. could make it more difficult for other Indian pharma companies to win new contracts with U.S. wholesalers.